Form 4: Integra LifeSciences CEO Jan De Witte Reports Stock Transactions
SEC Form 4 Filing
CEO Jan De Witte reports the vesting and subsequent disposal of Integra LifeSciences Holdings Corp stock units to cover tax obligations.
Summary
- On March 10, 2024, Jan De Witte, the President and CEO of Integra LifeSciences Holdings Corp, reported transactions involving common stock.
- 346 shares were acquired through the vesting of restricted stock units.
- Concurrently, 346 shares were disposed of at a price of $36.73 to satisfy tax obligations.
- Following these transactions, De Witte directly owns 18,350 shares of common stock and 89,071 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the trading activities of company leadership.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time.
- The sale of shares to cover tax obligations upon vesting is a standard practice among executives.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize stock-based compensation for their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The sale of shares to cover taxes may slightly increase the trading volume of the stock.
Key Dates
| Date | Description |
|---|---|
| 03/10/2023 | Grant date of the restricted stock unit award which will vest in three equal annual installments. |
| 03/10/2024 | Date of stock transactions: acquisition of 346 shares via vesting of restricted stock units and disposal of 346 shares to cover tax obligations. |
| 03/12/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.